![Denise Scots-Knight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Denise Scots-Knight
Fondateur chez
MEREO BIOPHARMA GROUP PLC
Fortune : 3 M $ au 31/05/2026
Profil
Denise Vera Scots-Knight is the founder of Mereo BioPharma Group Plc, founded in 2015, serving as Chief Executive Officer & Director.
Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Independent Director at Elanco Animal Health, Inc. since 2019, Director at Mereo BioPharma 4 Ltd. since 2017, and President at Mereo BioPharma 5, Inc. since 2019.
Former jobs include Chairman-Supervisory Board at Nabriva Therapeutics GmbH from 2007 to 2016, Managing Director at Nomura International Plc from 1999 to 2010, Director at ViaCell, Inc., Independent Director at Idenix Pharmaceuticals LLC from 2011 to 2014, Independent Director at Mereo BioPharma 5, Inc. from 2012 to 2018, Director at Cerimon Pharmaceuticals, Inc., Director at DeveloGen AG from 2011 to 2012, Director at Albireo Ltd., Director at Albireo AB, Independent Director at Albireo Pharma, Inc. from 2008 to 2017, Managing Partner at Phase4 Partners Ltd. from 2010 to 2016, Member at Rothschild Asset Management Ltd. from 1997 to 1999, and Trustee at British Heart Foundation from 2005 to 2012.
Education includes undergraduate studies at the University of California, Berkeley, and both undergraduate and doctorate degrees from the University of Birmingham.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 105 588 ( 0,02% ) | 3 M $ | 31/05/2026 | |
| 26/03/2026 | 4 044 609 ( 0,51% ) | 278 269 $ | 31/05/2026 |
Postes actifs de Denise Scots-Knight
| Sociétés | Poste | Début |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Fondateur | 10/07/2015 |
| ELANCO ANIMAL HEALTH INCORPORATED | Directeur/Membre du Conseil | 11/03/2019 |
| ONCOMED PHARMACEUTICALS INC | President | 23/04/2019 |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Directeur/Membre du Conseil | 18/06/2015 |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Directeur/Membre du Conseil | - |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Directeur/Membre du Conseil | 24/10/2017 |
Anciens postes connus de Denise Scots-Knight
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Directeur/Membre du Conseil | 28/09/2018 |
| ALBIREO PHARMA, INC. | Directeur/Membre du Conseil | 28/09/2017 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Président | 01/08/2016 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Denise Scots-Knight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Nomura International Plc
 Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Rothschild Asset Management Ltd.
 Rothschild Asset Management Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides investments on behalf of institutions, pension funds, and private clients | Miscellaneous |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic drugs | Health Technology |
British Heart Foundation
 British Heart Foundation Miscellaneous Commercial ServicesCommercial Services Provides fund services for hearts beating and blood flowing, heart and circulatory diseases | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Elanco Animal Health, Inc.
 Elanco Animal Health, Inc. BiotechnologyHealth Technology Develops parasitic-ides, vaccines, therapeutics, medicated feed additives and injectable antibiotics | Health Technology |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
